IRIS UniCatt

De Pascale, Gennaro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.218
NA - Nord America 3.665
AS - Asia 1.601
SA - Sud America 256
AF - Africa 31
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.623
DE - Germania 1.192
IT - Italia 817
SE - Svezia 708
SG - Singapore 572
CN - Cina 564
PL - Polonia 249
UA - Ucraina 229
IE - Irlanda 228
FR - Francia 218
BR - Brasile 194
GB - Regno Unito 148
ID - Indonesia 112
FI - Finlandia 107
TR - Turchia 106
IN - India 79
RU - Federazione Russa 73
NL - Olanda 54
HK - Hong Kong 45
AT - Austria 36
BE - Belgio 34
CA - Canada 26
ES - Italia 24
IR - Iran 24
AR - Argentina 19
CH - Svizzera 17
CO - Colombia 17
AU - Australia 16
JP - Giappone 16
CZ - Repubblica Ceca 15
KR - Corea 14
MX - Messico 11
VN - Vietnam 10
GR - Grecia 9
CI - Costa d'Avorio 7
CL - Cile 7
EE - Estonia 7
EG - Egitto 7
LT - Lituania 7
PE - Perù 7
PT - Portogallo 7
EU - Europa 6
IQ - Iraq 6
MK - Macedonia 6
RO - Romania 6
TW - Taiwan 6
VE - Venezuela 6
BG - Bulgaria 5
IL - Israele 5
MA - Marocco 5
UZ - Uzbekistan 5
VA - Santa Sede (Città del Vaticano) 5
KZ - Kazakistan 4
PH - Filippine 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
NO - Norvegia 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
GT - Guatemala 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 9.795
Salva come PNG Salva come JPEG
Città #
Chandler 713
Singapore 365
Ashburn 264
Dublin 227
Warsaw 211
Jacksonville 157
Ann Arbor 143
San Mateo 131
Nanjing 129
Milan 125
New York 125
Rome 122
Jakarta 111
Wilmington 91
Chicago 88
The Dalles 87
Nürnberg 84
Fairfield 83
Dearborn 82
Woodbridge 80
Seattle 70
Boston 65
Marseille 64
Izmir 63
Houston 61
Beijing 59
Cattolica 58
Helsinki 54
Munich 54
Moscow 52
Los Angeles 50
Redwood City 50
North Bergen 49
Nanchang 48
Princeton 46
Lawrence 40
Nuremberg 35
Hong Kong 34
Bremen 31
Kraków 30
Brussels 29
Kunming 29
Boardman 28
Cambridge 28
Redmond 23
Hangzhou 22
London 22
Augusta 20
Norwalk 20
Padova 20
Pune 20
Lancaster 19
Tianjin 19
Hebei 18
Mountain View 18
Kocaeli 17
Frankfurt am Main 16
Shenyang 15
University Park 15
Washington 15
Changsha 14
Falkenstein 14
Guangzhou 14
Kish 14
Vienna 14
Belo Horizonte 13
Jiaxing 13
Paris 13
Düsseldorf 12
San Diego 12
Verona 12
Brno 11
Falls Church 11
Leawood 11
Renton 11
Shanghai 11
Turin 11
Zhengzhou 11
Toronto 10
Zurich 10
Buenos Aires 9
Fremont 9
Hefei 9
Ottawa 9
Santa Clara 9
Seoul 9
Busto Arsizio 8
Jinan 8
Phoenix 8
São Paulo 8
Abidjan 7
Andover 7
Portsmouth 7
Bogotá 6
Brooklyn 6
Detroit 6
Florence 6
Istanbul 6
Lanzhou 6
Lappeenranta 6
Totale 5.235
Salva come PNG Salva come JPEG
Nome #
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 313
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 246
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 227
Colistin use in critically ill patients: in search of the optimal dosing. 212
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 212
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 184
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 183
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 170
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 170
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 167
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 152
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 146
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 146
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 143
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 136
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 136
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 133
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 133
Neurological involvement during legionellosis, look beyond the lung 129
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 129
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 125
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 124
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 122
Data on the application of early coagulation support protocol in the management of major trauma patients 121
The importance of airway and lung microbiome in the critically ill 120
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 117
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 115
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 110
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 109
Neurological involvement during Legionellosis, look beyond the lung 107
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 105
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 104
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 96
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 95
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 95
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 95
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 94
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 93
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 92
Noninvasive ventilation for the immunocompromised patient: always appropriate? 91
Sarilumab use in severe SARS-CoV-2 pneumonia 91
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 90
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 90
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 88
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 86
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 84
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 83
Lice, rodents, and many hopes: a rare disease in a young refugee 83
Aerosolized colistin cost-effectiveness. Response 82
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 82
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 82
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 81
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 79
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 79
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 78
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 77
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 75
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 74
The place of dexmedetomidine light sedation in patients with acute brain injury 74
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 73
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 73
Dose of colistin: a work in progress? 71
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough! 70
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 69
Fungal infections in the ICU: advances in treatment and diagnosis 68
Response 67
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 66
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 66
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 66
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 64
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 64
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 63
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 63
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 63
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 63
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 61
Hemadsorption 58
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 57
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study 56
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 56
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 56
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 55
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 54
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 53
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 51
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 51
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia 50
Lung Recruitability and Positive End-Expiratory Pressure Setting in ARDS Caused by COVID-19 49
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 47
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies 47
How to manage aspergillosis in non-neutropenic intensive care unit patients 46
Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial 45
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study 45
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 45
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 44
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 42
Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia 41
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 36
Physiological effects of awake prone position in acute hypoxemic respiratory failure 36
Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2 35
Totale 9.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020229 0 0 0 0 0 0 0 0 0 61 101 67
2020/2021808 39 69 23 55 82 65 103 32 99 54 137 50
2021/20221.104 90 73 67 69 85 58 24 166 59 72 164 177
2022/20232.154 230 268 137 296 145 236 107 204 248 109 110 64
2023/20241.365 79 280 64 60 67 201 100 96 42 78 145 153
2024/20251.775 80 69 202 129 187 113 179 137 434 245 0 0
Totale 9.968